182 related articles for article (PubMed ID: 18507342)
1. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Fan F; Sun XF
Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
Jiang S; Li M; Hu Y; Zhang Z; Lv H
Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma.
Yang H; Guo W; Xu B; Li M; Cui J
Anticancer Drugs; 2007 Nov; 18(10):1133-7. PubMed ID: 17893513
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
7. New Norcantharidin Analogs: Synthesis and Anticancer Activity.
Pachuta-Stec A; Szuster-Ciesielska A
Arch Pharm (Weinheim); 2015 Dec; 348(12):897-907. PubMed ID: 26548647
[TBL] [Abstract][Full Text] [Related]
8. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the liver targeting of norcantharindin microemulsion].
Zhang L; Xiang D; Hong Z; Zhang ZR
Yao Xue Xue Bao; 2004 Aug; 39(8):650-5. PubMed ID: 15563071
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics.
Xu X; Li Y; Wang F; Lv L; Liu J; Li M; Guo A; Jiang J; Shen Y; Guo S
Int J Pharm; 2013 Sep; 453(2):610-9. PubMed ID: 23742972
[TBL] [Abstract][Full Text] [Related]
11. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives.
Xu X; Li Y; Shen Y; Guo S
Int J Biol Macromol; 2013 Nov; 62():418-25. PubMed ID: 24099934
[TBL] [Abstract][Full Text] [Related]
13. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
14. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
15. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
[TBL] [Abstract][Full Text] [Related]
16. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
[TBL] [Abstract][Full Text] [Related]
17. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
Liang L; Zhao L; Wang Y; Wang Y
Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
[TBL] [Abstract][Full Text] [Related]
18. [Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin].
Tian SL; Zhao SW; Zhu AT; Fang Y; Li KQ
Yao Xue Xue Bao; 1993; 28(11):870-5. PubMed ID: 8010005
[TBL] [Abstract][Full Text] [Related]
19. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]